Robotic neurosurgery is a fast-growing technology owing to several advantages over the traditional neurology surgery such as better outcomes, increased accuracy, sooner recovery, shorter hospital stay, among others.
Highlighted with 94 tables and 69 figures, this 164-page report “Global Neurosurgical Robotics Market 2020-2027 by Product, Equipment Type, End User and Region: Market Size, Share, Forecast and Strategy” is based on a comprehensive research of the entire global neurosurgical robotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year.
Global neurosurgical robotics market will reach $2,010.7 million by 2027, growing by 16.8% annually over 2020-2027 driven by the growing incidents of neurological diseases, aging population, the improved benefits with robotics-based procedures, and decreasing price of robot-assisted neurology surgery.
The following aspects are identified and examined in-depth qualitative analyses:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
By taking COVID-19 into consideration, the trend and outlook for the global market are predicted with an upbeat, fair-minded, and conservative viewpoint. The global neurosurgery robotics market is quantified from the perspectives of Product, Equipment Type, End User, and Region using the balanced (most likely) forecast.
Request Research Sample with Latest Industry Insights: https://altusmarketresearch.com/reports/sample/3398
The global Neurosurgical Robotics Market is divided into the following sub-markets based on product, with annual revenue for 2017–2027 provided in each area.
• Robotic Systems
• Instruments and Accessories
• System Services
Based on Equipment Type, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Robot Machines
• Navigation Systems
• Planners and Simulators
• Other Equipment Types
Based on End User, the global Neurosurgical Robotics Market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Hospitals
• Ambulatory Surgical Centers
Along with the listed national/local markets, the following geographic areas are thoroughly investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
In Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• America, North (U.S., Canada, and Mexico)
Latin America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa) (UAE, Saudi Arabia, South Africa)
There are thorough analyses and data for annual revenue for each of the aforementioned regions and nations for the years 2017 through 2027. There is also a breakdown of the major national markets by Product, Equipment Type, and End User over the predicted years, as well as a breakdown of the regional markets by country.
The Neurosurgical Robotics Market study also analyses the present competition landscape, the anticipated trend, and it provides profiles of key vendors, including both established market leaders and significant up-and-coming companies.
Through AMR’s Risk Assessment System, possible risks related to investments in the worldwide neurosurgery robotics market and industry are evaluated quantitatively and qualitatively. Critical Success Factors (CSFs) are developed in accordance with the risk analysis and evaluation as a guide to assist investors and stockholders in managing and minimising the risks, developing suitable business models, and making informed strategies and decisions.
Key Players (this list may not be exhaustive; additional businesses can be included upon request):
Brainlab AG
DePuy Synthes (Johnson & Johnson)
Mazor Robotics Ltd.
Medtronic Inc.
Renishaw plc
Shenzhen Institutes of Advanced Technology (SIAT)
Siemens Healthineers
Simbionix USA Corp.
SONOWAND AS
Stryker Corp. / MAKO
Synaptive Medical, Inc.
Zimmer Biomet Holdings, Inc. / Medtech
